Loading...
NPI 1548255201 · Saint Louis, MO · Geriatric Medicine (Internal Medicine) Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Mohammed Mojid is a geriatric medicine (internal medicine) physician provider located in Saint Louis, Missouri. This profile covers 14 Medicare and 5 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Mohammed Mojid |
| Address | 12700 Southfork Rd |
| City | Saint Louis |
| State | MO |
| ZIP | 63128 |
| Taxonomy | Geriatric Medicine (Internal Medicine) Physician |
| NPI Enumerated | September 19, 2005 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $114.8K |
| Medicaid | $5.1K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
14 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 360 | $110 | $41K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 140 | $150 | $21K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 200 | $90 | $17.4K |
| 87811 | The lab analyst performs the technical lab test to analyze for the presence of severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2) (Coronavirus disease [COVID–19]) in a specimen by… | 220 | $40 | $9K |
| 95004 | The provider performs a percutaneous test with allergenic extracts to determine which substances (allergens) trigger an allergic reaction in the patient. | 2,240 | $1 | $9K |
| 99203 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the provider… | 70 | $110 | $7.8K |
| 87637 | The lab analyst performs the technical steps to detect and differentiate severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2), influenza A, influenza B, and respiratory syncytial virus (RSV)… | 50 | $140 | $6.9K |
| 87804 | The analyst performs an immunoassay with direct optical, meaning visual, observation to detect influenza, also called flu, in a patient sample, typically a throat or nasal swab or nasal washings. | 60 | $20 | $930 |
| 87880 | The analyst performs an immunoassay with direct optical, meaning visual, observation to detect Streptococcus, group A, in a patient sample, typically a throat swab. | 30 | $20 | $530 |
| 87428 | The lab analyst performs an immunoassay to qualitatively or semiquantitatively evaluate the patient specimen for antigens of severe acute respiratory syndrome (SARS) coronavirus, such as SARS–CoV–2… | 20 | $30 | $480 |
Showing 1–10 of 14
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 14 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
14 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 99214 | 1,276 | 8,960 | 100 | $80 | $13.9K |
| 99213 | 1,622 | 8,730 | 70 | $50 | $7K |
| 95004 | 9 | 70 | 1,140 | $1 | $4.9K |
| 99204 | 157 | 4,360 | 30 | $100 | $4.8K |
| 87637 | 5 | 30 | 30 | $140 | $4.7K |
| 99203 | 577 | 2,950 | 30 | $70 | $3.2K |
| 36415 | 1,516 | 1,570 | 110 | $10 | $1.9K |
| 71046 | 1,065 | 1,130 | 50 | $10 | $1.6K |
| 87811 | 1 | 150 | 30 | $40 | $1.5K |
| 87428 | 150 | 240 | 20 | $50 | $1.3K |
Showing 1–10 of 14
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
5 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99203 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the provider… | 60 | $40 | $2.4K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 30 | $50 | $1.3K |
| 87635 | Using an amplified nucleic acid probe technique, the lab analyst performs the necessary steps to identify the nucleic acids from the severe acute respiratory syndrome coronavirus 2 (SARS–COV–2) virus… | 30 | $30 | $960 |
| 87811 | The lab analyst performs the technical lab test to analyze for the presence of severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2) (Coronavirus disease [COVID–19]) in a specimen by… | 10 | $40 | $490 |
| 99000 | Use this code for the in office preparation of a specimen for lab analysis and or its transport from the office to the outside testing laboratory. | 30 | $0 | $0 |
How this provider's Medicaid billing volume and revenue compare to other Missouri providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Missouri median
5 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 2,620 | 3,170 | 230 | $70 | $128.1K |
| 87635 | Using an amplified nucleic acid probe technique, the lab analyst performs the necessary steps to identify the nucleic acids from the severe acute respiratory syndrome coronavirus 2 (SARS–COV–2) virus… | 144 | 180 | 210 | $30 | $34.5K |
| 99203 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the provider… | 440 | 860 | 60 | $70 | $33.9K |
| 87811 | The lab analyst performs the technical lab test to analyze for the presence of severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2) (Coronavirus disease [COVID–19]) in a specimen by… | 44 | 50 | 100 | $30 | $16.1K |
| 99000 | Use this code for the in office preparation of a specimen for lab analysis and or its transport from the office to the outside testing laboratory. | 14 | 20 | 270 | $20 | $6.2K |
Other providers in the same ZIP code as Mohammed Mojid, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Mercy Hospital South | MO | General Acute Care Hospital | $0 | $22M |
| St Anthonys Physician Organization Hospitalist Services, L.c. | MO | Hospitalist Physician | $0 | $4.2M |
| Nabil Tauk | MO | Nephrology Physician | $315K | $969.7K |
| Navin Tekwani | MO | Ophthalmology Physician | $533.8K | $0 |
| Lawrence Wang | MO | Dermatology Physician | $318.8K | $0 |
| Iqbal Amin | MO | Geriatric Medicine (Internal Medicine) Physician | $309.8K | $0 |
| Miguel Gelman | MO | Diagnostic Radiology Physician | $168.3K | $140.8K |
| K. Thampy | MO | Endocrinology, Diabetes & Metabolism Physician | $307.6K | $0 |
| Danish Jabbar | MO | Internal Medicine Physician | $295.6K | $0 |
| Jeffrey Judd | MO | Diagnostic Radiology Physician | $244.2K | $30.2K |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.